Septic Shock clinical trials at UC Davis
1 research study open to eligible people
A Study of Different Ways to Use Intravenous Fluids (given through a vein) and Vasopressors (blood pressure medicine) for Sepsis
open to eligible people ages 18 years and up
Multicenter, prospective, phase 3 randomized non-blinded interventional trial of fluid treatment strategies in the first 24 hours for patients with sepsis-induced hypotension. The aim of the study is to determine the impact of a restrictive fluids strategy (vasopressors first followed by rescue fluids) as compared to a liberal fluid strategy (fluids first followed by rescue vasopressors) on 90-day in-hospital mortality in patients with sepsis-induced hypotension.
San Francisco, California and other locations